Health insurers will cover 8 home COVID-19 tests a month starting Saturday, Biden administration says
![COVID-19 home tests](https://cdn.mos.cms.futurecdn.net/k2gQuwhTcnKvJSnWrCS4S-415-80.jpg)
Private health insurers will be required to cover the costs for up to eight home COVID-19 tests a month for every person on their plans, beginning Saturday, under a new policy the Biden administration detailed Monday. The administration is offering incentives for insurers and group health plans to partner with specific retailers so members can get tests with no upfront costs, but everyone with private insurance will be able to get reimbursed for tests purchased Jan. 15 or later.
After taking flak in December for a national shortage of test kits over the holidays, just as the Omicron variant started sweeping through the U.S., the Biden administration "is working to make COVID-19 home tests more accessible, both by increasing supply and bringing down costs," The Associated Press reports. People without private insurance or on Medicare will be able to request free kits directly from the federal government through a website the Biden administration is set to launch later this month.
The two main U.S. insurance trade groups said they will work to carry out the new requirements "in ways that limit consumer confusion and challenges," as Matt Eyles, president of America's Health Insurance Plans, said in a statement. Kim Keck, president of the Blue Cross Blue Shield Association, expressed concern "that the policy does not solve for the limited supply of tests in the country."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The research is mixed on how effective the rapid at-home antigen tests are at detecting Omicron infections, The Wall Street Journal reports, and there are special concerns about false negatives early in an infection. If used correctly, though, they are an important tool for limiting the spread of the highly transmissible variant.
There are several approved at-home tests, and if you have a choice, the nonprofit group ECRI rates On/Go, CareStart, and Flowflex brand tests as "very good"; QuickVue, BinaxNOW, and InteliSwab as "good"; and BD Veritor as "OK (Marginally Acceptable)." You can read the pros and cons of each at-home test in their report.
The new Biden administration policy "will help millions of families afford COVID tests that allow them to be in school, visit family members, and live their lives," Sabrina Corlette, co-director of Georgetown University's Center on Health Insurance Reforms, tells the Journal. "It's not perfect, and there will be glitches, but the cost of these tests has been a huge barrier for many people, and this policy helps lower that."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
Big Tech's answer for AI-driven job loss: universal basic income
In The Spotlight A new study reveals the strengths and limitations
By Joel Mathis, The Week US Published
-
'I will not be silent' on Gaza, says Kamala Harris
Speed Read In a meeting with Israeli Prime Minister Benjamin Netanyahu, Harris supported Israel's right to defend itself while expressing a desire to end Palestinian suffering
By Arion McNicoll, The Week UK Published
-
'How long can TikTok dominate as a social network?'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published